Mark S. Marshall

10.5k total citations · 3 hit papers
90 papers, 8.9k citations indexed

About

Mark S. Marshall is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Mark S. Marshall has authored 90 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 23 papers in Oncology and 15 papers in Cell Biology. Recurrent topics in Mark S. Marshall's work include Protein Kinase Regulation and GTPase Signaling (39 papers), Melanoma and MAPK Pathways (16 papers) and Cancer-related Molecular Pathways (13 papers). Mark S. Marshall is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (39 papers), Melanoma and MAPK Pathways (16 papers) and Cancer-related Molecular Pathways (13 papers). Mark S. Marshall collaborates with scholars based in United States, United Kingdom and Japan. Mark S. Marshall's co-authors include W. Wayt Gibbs, Edward M. Scolnick, Darlene Barnard, Irving S. Sigal, Michael D. Schaber, Bruce Diaz, Joseph Avruch, Alastair J. King, Ursula Vogel and Xianfeng Zhang and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Mark S. Marshall

89 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1

1993 760 citations Xianfeng Zhang, Mark S. Marshall et al. Nature profile →
Cloning of bovine GAP and its interaction with oncogenic ras p21

1988 601 citations Ursula Vogel, Richard A. F. Dixon et al. Nature profile →
Sequence dependence of protein isoprenylation

1991 503 citations Michael D. Schaber, Mark S. Marshall et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark S. Marshall United States	47	7.4k	2.0k	1.7k	715	600	90	8.9k
Patricia H. Warne United Kingdom	25	5.8k 0.8×	1.8k 0.9×	1.2k 0.7×	938 1.3×	705 1.2×	30	7.3k
Michael F. Moran Canada	44	5.5k 0.8×	1.5k 0.8×	1.2k 0.7×	816 1.1×	477 0.8×	120	7.3k
Vincent J. Kidd United States	47	5.3k 0.7×	2.0k 1.0×	1.1k 0.6×	856 1.2×	1.1k 1.9×	100	7.2k
Pablo Rodriguez‐Viciana United States	24	5.2k 0.7×	1.5k 0.8×	1.1k 0.7×	731 1.0×	572 1.0×	31	6.3k
Román Herrera United States	26	6.7k 0.9×	1.8k 0.9×	812 0.5×	860 1.2×	738 1.2×	42	8.6k
Stuart J. Decker United States	37	5.3k 0.7×	2.1k 1.1×	867 0.5×	1.1k 1.5×	802 1.3×	67	7.8k
Hugh Paterson United Kingdom	29	5.3k 0.7×	1.4k 0.7×	1.8k 1.0×	468 0.7×	548 0.9×	52	6.7k
Shubha Bagrodia United States	27	5.5k 0.7×	1.3k 0.6×	2.3k 1.4×	753 1.1×	626 1.0×	39	7.4k
Kent L. Rossman United States	37	6.9k 0.9×	1.5k 0.7×	2.8k 1.6×	693 1.0×	641 1.1×	51	8.8k
Jean Y. J. Wang United States	56	8.3k 1.1×	4.5k 2.2×	1.4k 0.8×	807 1.1×	1.2k 2.0×	127	11.6k

Countries citing papers authored by Mark S. Marshall

Since Specialization

Citations

This map shows the geographic impact of Mark S. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Marshall more than expected).

Fields of papers citing papers by Mark S. Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Marshall. The network helps show where Mark S. Marshall may publish in the future.

Co-authorship network of co-authors of Mark S. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Marshall. A scholar is included among the top collaborators of Mark S. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Marshall. Mark S. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marshall, Mark S., et al.. (2023). Targeted treatment of refractory primitive neuroectodermal tumor arising from an immature teratoma with crizotinib leading to a sustained response. SHILAP Revista de lepidopterología. 11(1). e6779–e6779. 2 indexed citations

Marshall, Mark S., et al.. (2023). Pediatric precision oncology: “better three hours too soon than a minute too late”. Frontiers in Oncology. 13. 1279953–1279953.

Marshall, Mark S., et al.. (2020). Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant. PMC. 3 indexed citations

King, Constance, Samuel McNeely, Darlene Barnard, et al.. (2015). LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms. Molecular Cancer Therapeutics. 14(9). 2004–2013. 139 indexed citations

Corbit, Kevin C., Nicholas Trakul, Eva M. Eves, et al.. (2003). Activation of Raf-1 Signaling by Protein Kinase C through a Mechanism Involving Raf Kinase Inhibitory Protein. Journal of Biological Chemistry. 278(15). 13061–13068. 287 indexed citations

Shi, Zhongqing, Dehua Yu, Morag Park, Mark S. Marshall, & Gen‐Sheng Feng. (2000). Molecular Mechanism for the Shp-2 Tyrosine Phosphatase Function in Promoting Growth Factor Stimulation of Erk Activity. Molecular and Cellular Biology. 20(5). 1526–1536. 199 indexed citations

Yang, Feng‐Chun, Reuben Kapur, Alastair J. King, et al.. (2000). Rac2 Stimulates Akt Activation Affecting BAD/Bcl-XL Expression while Mediating Survival and Actin Function in Primary Mast Cells. Immunity. 12(5). 557–568. 142 indexed citations

Luo, Zhijun, Bruce Diaz, Mark S. Marshall, & Joseph Avruch. (1997). An Intact Raf Zinc Finger Is Required for Optimal Binding to Processed Ras and for Ras-Dependent Raf Activation In Situ. Molecular and Cellular Biology. 17(1). 46–53. 105 indexed citations

Diaz, Bruce, Darlene Barnard, Adele J. Filson, et al.. (1997). Phosphorylation of Raf-1 Serine 338-Serine 339 Is an Essential Regulatory Event for Ras-Dependent Activation and Biological Signaling. Molecular and Cellular Biology. 17(8). 4509–4516. 175 indexed citations

10.

Zhang, Xianfeng, et al.. (1997). Characterization of the Ras Binding Domain of the RalGDS-Related Protein, RLF. Biochemical and Biophysical Research Communications. 238(2). 425–429. 4 indexed citations

11.

Marshall, Mark S., et al.. (1995). [6] Mutagenesis and biochemical analysis of recombinant yeast prenyltransferases. Methods in enzymology on CD-ROM/Methods in enzymology. 250. 51–68. 6 indexed citations

12.

Marshall, Mark S.. (1995). Interactions between Ras and Raf: Key regulatory proteins in cellular transformation. Molecular Reproduction and Development. 42(4). 493–499. 84 indexed citations

13.

Chuang, Ellen, et al.. (1994). Critical Binding and Regulatory Interactions between Ras and Raf Occur through a Small, Stable N-Terminal Domain of Raf and Specific Ras Effector Residues. Molecular and Cellular Biology. 14(8). 5318–5325. 39 indexed citations

14.

Marshall, Mark S., Lenora J. Davis, Robert D. Keys, et al.. (1991). Identification of Amino Acid Residues Required for Ras p21 Target Activation. Molecular and Cellular Biology. 11(8). 3997–4004. 8 indexed citations

15.

Farnsworth, Charles L., Mark S. Marshall, W. Wayt Gibbs, Dennis W. Stacey, & Larry A. Feig. (1991). Preferential inhibition of the oncogenic form of RasH by mutations in the GAP binding/“effector” domain. Cell. 64(3). 625–633. 75 indexed citations

16.

Nakafuku, Masato, Mark S. Marshall, W. Wayt Gibbs, et al.. (1990). S. cerevisiae genes IRA1 and IRA2 encode proteins that may be functionally equivalent to mammalian ras GTPase activating protein. Cell. 60(5). 803–807. 294 indexed citations

17.

Schaber, Michael D., Victor M. Garsky, W S Hill, et al.. (1989). Ras interaction with the GTPase‐activating protein (GAP). Proteins Structure Function and Bioinformatics. 6(3). 306–315. 85 indexed citations

18.

Vogel, Ursula, Richard A. F. Dixon, Michael D. Schaber, et al.. (1988). Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature. 335(6185). 90–93. 601 indexed citations breakdown →

19.

Sigal, Irving S., Mark S. Marshall, Michael D. Schaber, et al.. (1988). Structure/Function Studies of the ras Protein. Cold Spring Harbor Symposia on Quantitative Biology. 53(0). 863–869. 19 indexed citations

20.

Marshall, Mark S., W. Wayt Gibbs, Edward M. Scolnick, & Irving S. Sigal. (1987). Regulatory Function of the Saccharomyces cerevisiae Ras C-Terminus. Molecular and Cellular Biology. 7(7). 2309–2315. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact